Hypofibrinogenemia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Clinical Trials

Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
Conditions:   Congenital Afibrinogenemia;   Congenital HypofibrinogenemiaIntervention:   Biological: BT524 (fibrinogen concentrate from human plasma)Sponsors:   Biotest;   Aptiv Solutions;   Interlab;   Phoenix Clinical ResearchRecruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 3, 2014 Category: Research Source Type: clinical trials